T-Knife Therapeutics
Biotechnology
T-Knife Therapeutics valuation and funding history | Last updated: August 2, 2021 | 1 funding rounds
Current Valuation
N/A
As of August 2, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Later Stage VC (Series B)
$110.0M
Last Funding
Aug 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| August 2, 2021 | Later Stage VC (Series B) | $110.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
T-Knife Therapeutics is currently valued at N/A as of August 2, 2021.
What is T-Knife Therapeutics Worth in 2026?
T-Knife Therapeutics is a leading private company in the Biotechnology sector. Track T-Knife Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How T-Knife Therapeutics Valuation is Determined
Private company valuations like T-Knife Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.